Insider Transactions Reported by 24 Insiders of Royalty Pharma plc

Symbol
RPRX on Nasdaq
Location
New York, NY

Insiders trading volume in the past year

Royalty Pharma plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Pablo G. Legorreta CEO, Chairman of the Board, Director $2.76B 05 Nov 2025
GG 1978 SICAF SIF S.A. 10%+ Owner $608M 14 Sep 2022
GG 1978 SICAF SIF S.A. - GG Strategic 10%+ Owner $590M 20 Sep 2022
George W. Lloyd EVP, Investments & CLO $301M -$13.8M -4.39% 17 Dec 2025
Terrance P. Coyne Evp & Cfo $255M -$10.9M -4.09% 15 Dec 2025
Mario Germano Giuliani Director, 10%+ Owner $96M 23 Jun 2023
WILLIAM E. FORD Director $71.2M 30 Jun 2021
Avara Management Ltd 10%+ Owner $68.5M 29 Dec 2023
Christopher Hite EVP & Vice Chairman $25.7M 05 Nov 2025
James F. Reddoch EVP & Chief Scientific Officer $23.3M 28 Sep 2022
RORY B. RIGGS Director $11.6M 20 Feb 2024
Gregory Norden Director $7.06M -$1.21M -14.7% 08 Aug 2025
Marshall Urist EVP, Research & Investments $5.65M -$4.82M -46% 19 Dec 2025
ERROL B. DESOUZA Director $4.83M 13 May 2025
Henry A. Fernandez Director $4.19M 30 Jun 2025
TED W. LOVE Director $3.12M 13 May 2025
Catherine M. Engelbert Director $2.95M 13 May 2025
Bonnie L. Bassler Director $2.58M 30 Sep 2025
DAVID C. HODGSON Director $1.84M 13 May 2025
Vlad Coric Director $345K 13 May 2025
Carole Ho Director $307K 31 Jul 2025
ELIZABETH H. WEATHERMAN Director $307K 31 Jul 2025
Royalty Pharma plc Director $0 07 Apr 2025
MGG Strategic SICAF SIF S.A. 10%+ Owner 01 Apr 2022

Recent Insider Transactions by Companies or Individuals for Royalty Pharma plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.